Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer
The approval was based on data from the phase 3 TOPAZ-1 trial.
Biliary Tract Cancer
Increasing BMI Tied to Higher Risk of Liver and Biliary Tract Cancers
Individuals who are overweight or obese, or who become overweight or obese over time, have a higher risk of liver cancer and biliary tract cancer.
OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
In a phase 3 study presented at the 2018 Gastrointestinal Cancers Symposium, researchers reported on OS outcomes with gemcitabine plus S-1 vs gemcitabine plus cisplatin in patients with advanced biliary tract cancer.
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
[Clinical Medicine Insights: Oncology] This research examines the role of adjuvant chemotherapy in resectable bile duct cancer treatment.
Regular Aspirin Use May Protect Against Bile Duct Cancer
People who took aspirin on a regular basis were three times less likely to develop the disease.
Adding Panitumumab to Chemo Does Not Prolong Survival in Wild-Type Biliary Tract Cancer
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer.
Bile duct cancer study may pave way for new treatments
Patients with bile duct cancer could be helped by a new class of experimental drug, according to a study.
Adjuvant therapy shows promise in biliary tract cancer
Nonsignificant improvement in unselected patients, but significant benefit for high-risk patients.
More evidence shows aspirin might stave off cancer
Results from three new studies are consistent with earlier findings that aspirin can reduce cancer risk and, in some cases, metastasis.
Regular Aspirin Use Can Lower Cancer Risk, Studies Confirm
Aspirin use lowers the risk of esophageal, gastric, biliary, and breast cancer and reduces distant metastases.
- Loading...
Loading...
Loading... 
Loading...